Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 16 June 2014 | By Alexander Gaffney, RAC,
The Center for Devices and Radiological Health (CDRH), the US Food and Drug Administration's (FDA) device regulatory branch, has a question for industry: How have we helped you lately?
It's a bit of an odd question without context.
In February 2014, CDRH launched a new document, CDRH 2014-2015 Strategic Priorities, in which it said the device center would be focusing on three things in 2014: strengthening clinical trials, balancing pre- and post-market data collection requirements so as to expedite approvals, and trying to "provide excellent customer service."
The last one seemed a bit out of place among the lofty goals set by the first two, but CDRH said that it was part of an overall strategy to make the US "the country of first choice" for companies looking to bring new technologies to market.
Right now, many of those companies go to other countries, such as Europe, where the path to market (though not necessarily government reimbursement) is seen as being faster than it is in the US.
And creating a favorable climate for innovation involves making sure that regulators are responsive to not only the needs of innovators, but their questions as well.
As explained by FDA:
"Excellent customer service means understanding and addressing, as appropriate, stakeholders’ and colleagues’ needs through active listening, problem solving, seeking out the ideas of others, explaining the rationale for our decisions and requests for information, learning from our mistakes, and doing our best. Providing excellent customer service improves our interactions with stakeholders and colleagues and supports better regulatory outcomes, thereby improving patient health."
Good customer service, FDA continues, "requires identifying and meeting our customers' needs, as appropriate, while achieving our mission and vision.”
Accordingly, FDA has set lofty goals for its customer satisfaction ratings, hoping that at least 90% of customers will have a satisfactory interaction with the agency by the end of 2015.
For now, though, it's looking to end 2014 with at least a 70% satisfaction rating.
So, FDA is now asking: How has CDRH helped you lately, and was its response to your satisfaction?
The center has released a new "CDRH Customer Satisfaction Survey," asking members of industry how satisfied they were with their customer service, and then drilling into the details of those interactions, including the department involves, the demeanor of the CDRH employee, and even soliciting ideas for improvement from the respondent.
The results from the surveys will be posted monthly starting in August 2014, CDRH said in a statement on its website.
CDRH Customer Service
Tags: Customer Satisfaction Survey, CDRH Strategic Priorities, Innovation
Regulatory Focus newsletters
All the biggest regulatory news and happenings.